![](/img/cover-not-exists.png)
Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab
Cizkova, M, Dujaric, M-E, Lehmann-Che, J, Scott, V, Tembo, O, Asselain, B, Pierga, J-Y, Marty, M, de Cremoux, P, Spyratos, F, Bieche, IVolume:
108
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2013.164
Date:
March, 2013
File:
PDF, 247 KB
english, 2013